Search by Drug Name or NDC

    NDC 54838-0133-40 Siltussin DM DAS Cough Formula 10; 100 mg/5mL; mg/5mL Details

    Siltussin DM DAS Cough Formula 10; 100 mg/5mL; mg/5mL

    Siltussin DM DAS Cough Formula is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 54838-0133
    Product ID 54838-133_77e74ca8-1539-444b-b810-3115b3a8a154
    Associated GPIs 43997002520910
    GCN Sequence Number 000652
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-10MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53491
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Siltussin DM DAS Cough Formula
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin and Dextromethorphan Hydrobromide
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 10; 100
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name Lannett Company, Inc.
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 54838-0133-40 (54838013340)

    NDC Package Code 54838-133-40
    Billing NDC 54838013340
    Package 118 mL in 1 BOTTLE, PLASTIC (54838-133-40)
    Marketing Start Date 1995-09-05
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.0181
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description SILTUSSIN DM DAS 100-10 MG/5 ML
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 22f0e46f-b98c-4b7a-957a-fe49565fa41e Details

    Revised: 5/2019